A detailed history of Primecap Management CO transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Primecap Management CO holds 2,472,020 shares of IMCR stock, worth $69.6 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,472,020
Previous 1,951,070 26.7%
Holding current value
$69.6 Million
Previous $66.1 Million 16.38%
% of portfolio
0.06%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$30.06 - $41.49 $15.7 Million - $21.6 Million
520,950 Added 26.7%
2,472,020 $77 Million
Q2 2024

Aug 09, 2024

BUY
$33.78 - $63.75 $64.2 Million - $121 Million
1,901,570 Added 3841.56%
1,951,070 $66.1 Million
Q1 2024

May 13, 2024

BUY
$60.14 - $75.36 $2.98 Million - $3.73 Million
49,500 New
49,500 $3.22 Million

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.24B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.